Schedule 13G ownership disclosure
OptimizeRx Corp
Common Stock · CUSIP: 68401U204
Event date: 2025-09-30
- Filing-level shares
- 1,059,109
- Percent of class
- 5.70%
- The Vanguard Group
Shares: 1,059,109 · Class: 5.70%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000102909-25-000249
- Form type
- SCHEDULE 13G
- Filer
- OptimizeRx Corp
- CIK
- CIK 1448431
- Filed
- Oct 31, 2025
- Reporting period
- Sep 30, 2025
- Description
- Schedule 13G beneficial ownership